Complete Filing Data
NEKTAR THERAPEUTICS reported Net Income Loss of -$164.08 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NEKTAR THERAPEUTICS did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$164.1M | -$119.0M | -$276.1M | -$368.2M | -$523.8M | -$444.4M | -$440.7M | $681.3M | -$96.7M | -$153.5M | -$81.2M | -$53.9M | -$162.0M | -$171.9M | -$134.0M | -$37.9M | -$102.5M |
| Cost of Revenue * | $0.00 | $30.7M | $33.8M | $21.6M | $24.9M | $19.5M | $21.4M | $24.4M | $30.5M | $30.2M | $34.1M | $28.5M | $38.5M | $30.4M | $21.9M | $25.7M | $30.9M |
| Revenue * | $55.2M | $98.4M | $90.1M | $92.1M | $101.9M | $152.9M | $114.6M | $1.19B | $307.7M | $165.4M | $230.8M | $200.7M | $148.9M | $81.2M | $71.5M | $159.0M | $71.9M |
| Research And Development Expense | $117.3M | $120.9M | $114.2M | $218.3M | $400.3M | $408.7M | $434.6M | $399.5M | $268.5M | $203.8M | $182.8M | $147.7M | $190.0M | $148.7M | $126.8M | $108.1M | $95.1M |
| Operating Income Loss | -$140.1M | -$105.2M | -$263.7M | -$376.2M | -$446.1M | -$425.1M | -$440.0M | $687.9M | -$59.6M | -$112.9M | -$29.4M | -$16.5M | -$120.1M | -$141.2M | -$123.9M | -$28.3M | -$95.1M |
| Comprehensive Income Net Of Tax | -$164.1M | -$119.0M | -$269.1M | -$370.9M | -$525.7M | -$445.7M | -$435.4M | $677.1M | -$96.4M | -$153.7M | -$81.8M | -$54.3M | -$162.8M | -$171.1M | -$136.0M | -$38.0M | -$102.9M |
| General And Administrative Expense | $68.7M | $76.8M | $77.4M | $92.3M | $122.8M | $104.7M | $98.7M | $81.4M | $52.4M | $44.3M | $43.3M | $40.9M | $40.5M | $41.6M | $46.8M | $41.0M | $41.0M |
| Other Nonoperating Income Expense | $361.0K | -$390.0K | -$6.2M | -$116.0K | -$162.0K | $18.3M | $46.3M | $37.6M | $4.5M | $2.4M | $1.7M | $814.0K | $1.1M | $3.3M | -$1.0M | $827.0K | $848.0K |
| Nonoperating Income Expense | -$15.4M | -$14.0M | -$12.6M | $11.2M | -$77.2M | -$18.8M | -$19.0K | -$5.2M | -$36.4M | -$39.8M | -$51.3M | -$37.9M | -$39.6M | -$30.2M | -$9.0M | -$8.8M | -$7.6M |
| Income Tax Expense Benefit | -$138.0K | -$239.0K | -$200.0K | $3.2M | $557.0K | $493.0K | $613.0K | $1.4M | $616.0K | $876.0K | $506.0K | -$512.0K | $2.2M | $406.0K | $1.0M | $881.0K | -$253.0K |
| Non Cash Interest Expense Related To Sale Of Royalties | $26.2M | $28.1M | $25.3M | $28.9M | $47.3M | $30.3M | $25.0M | $21.2M | $18.9M | $19.7M | $20.6M | $20.9M | $22.3M | $18.1M | |||
| Interest Expense | $0.00 | $0.00 | $6.9M | $21.3M | $21.6M | $22.1M | $22.5M | $18.3M | $17.9M | $18.5M | $15.5M | $10.2M | $11.2M | $12.2M | |||
| Non Cash Royalty Revenue Related To Sale Of Future Royalties | $54.9M | $64.3M | $68.9M | $69.8M | $77.7M | $48.6M | $36.3M | $33.3M | $30.5M | $30.2M | $22.1M | $21.9M | $22.1M | $10.8M | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$119.2M | -$276.3M | -$365.0M | -$523.3M | -$443.9M | -$440.1M | $682.7M | -$96.1M | -$152.6M | -$80.7M | -$54.4M | -$159.8M | |||||
| Other Comprehensive Income Loss Net Of Tax | -$44.0K | -$19.0K | $7.0M | -$2.8M | -$1.9M | -$1.3M | $5.3M | -$4.2M | $252.0K | -$193.0K | -$603.0K | -$386.0K | -$824.0K | $746.0K | -$2.1M | -$57.0K | |
| License Collaboration Other Revenue | $211.0M | $60.4M | $165.6M | $153.3M | $80.9M | $30.1M | $36.3M | $124.4M | $36.6M | ||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$26.0K | -$4.0K | $5.2M | -$1.6M | -$294.0K | -$363.0K | -$382.0K | -$1.2M | $785.0K | -$272.0K | -$377.0K | -$291.0K | -$1.0M | ||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$18.0K | -$15.0K | $1.8M | -$1.1M | -$1.6M | -$927.0K | $5.7M | -$3.0M | -$533.0K | $79.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$35.5M | -$41.6M | -$50.9M | -$37.1M | -$52.4M | -$36.8M | -$45.8M | -$51.1M | -$137.0M | -$59.0M | -$159.1M | -$90.4M | -$145.6M | -$129.7M | -$125.5M | -$123.0M | -$117.2M | -$108.6M | -$80.0M | -$138.7M | -$112.2M | -$98.6M | -$110.3M | -$119.6M | -$98.2M | -$96.1M | $971.5M | -$95.8M | -$33.8M | $60.9M | -$59.9M | -$63.9M | -$42.2M | -$43.2M | -$48.6M | -$19.5M | -$54.1M | -$8.2M | -$52.7M | $33.8M | -$45.7M | $70.6M | -$32.6M | -$46.2M | -$47.7M | -$16.5M | -$42.7M | -$55.1M | -$52.9M | -$43.5M | -$34.3M | -$41.1M | -$37.5M | -$24.1M | -$36.4M | -$36.0M | -$22.6M | -$8.7M | -$517.0K | -$6.1M |
| Cost of Revenue * | $0.00 | $0.00 | $0.00 | $4.4M | $9.7M | $8.5M | $12.4M | $7.0M | $7.1M | $5.0M | $5.1M | $5.3M | $6.2M | $5.3M | $7.7M | $5.8M | $4.3M | $5.6M | $5.8M | $3.8M | $6.0M | $4.9M | $5.0M | $5.4M | $7.5M | $4.8M | $5.5M | $6.6M | $9.8M | $5.7M | $9.0M | $6.1M | $6.6M | $7.0M | $7.7M | $8.9M | $8.4M | $6.8M | $10.5M | $8.4M | $6.3M | $9.2M | $5.1M | $7.9M | $9.0M | $12.9M | $5.0M | $11.7M | $7.3M | $7.2M | $7.2M | $8.7M | $5.5M | $5.0M | $8.1M | $3.3M | $6.2M | $4.9M | $4.3M | |
| Revenue * | $11.8M | $11.2M | $10.5M | $24.1M | $23.5M | $21.6M | $24.1M | $20.5M | $21.6M | $23.6M | $21.6M | $24.8M | $25.0M | $24.9M | $28.3M | $23.6M | $23.5M | $30.0M | $48.8M | $50.6M | $33.9M | $29.2M | $23.3M | $28.2M | $39.8M | $27.8M | $1.09B | $38.0M | $95.5M | $152.9M | $34.6M | $24.7M | $37.5M | $36.3M | $32.8M | $58.9M | $39.4M | $60.0M | $22.7M | $108.8M | $19.6M | $132.9M | $28.5M | $19.8M | $31.1M | $60.9M | $33.9M | $23.0M | $21.1M | $18.4M | $23.7M | $17.9M | $15.8M | $27.1M | $17.3M | $11.3M | $45.3M | $37.9M | $42.6M | $33.2M |
| Research And Development Expense | $27.3M | $29.9M | $30.5M | $35.0M | $29.7M | $27.4M | $24.1M | $29.7M | $30.5M | $33.6M | $42.7M | $107.3M | $99.6M | $103.7M | $101.3M | $95.6M | $102.7M | $100.5M | $96.4M | $109.0M | $110.4M | $99.0M | $106.7M | $118.5M | $108.9M | $102.9M | $88.3M | $99.4M | $81.4M | $65.7M | $60.3M | $61.1M | $50.2M | $52.0M | $52.4M | $49.3M | $47.1M | $43.2M | $45.4M | $47.0M | $38.5M | $34.2M | $36.7M | $38.3M | $48.2M | $43.9M | $52.2M | $45.6M | $46.4M | $34.0M | $33.2M | $35.1M | $33.3M | $31.0M | $32.3M | $30.2M | $31.5M | $27.7M | $25.6M | $23.3M |
| Operating Income Loss | -$31.7M | -$36.2M | -$44.5M | -$34.3M | -$49.8M | -$35.4M | -$44.9M | -$50.6M | -$134.7M | -$54.3M | -$152.8M | -$116.6M | -$112.9M | -$113.6M | -$110.2M | -$109.4M | -$110.7M | -$103.1M | -$77.7M | -$133.6M | -$109.6M | -$98.7M | -$111.0M | -$120.7M | -$100.3M | -$98.6M | $973.6M | -$86.7M | -$24.0M | $69.5M | -$50.7M | -$54.4M | -$32.1M | -$32.9M | -$38.3M | -$9.5M | -$29.4M | $419.0K | -$43.5M | $43.0M | -$37.5M | $80.3M | -$22.9M | -$36.4M | -$35.9M | -$6.5M | -$32.6M | -$45.1M | -$43.4M | -$32.9M | -$27.0M | -$37.9M | -$34.5M | -$21.3M | -$34.3M | -$33.9M | -$20.5M | -$6.2M | $1.9M | -$3.4M |
| Comprehensive Income Net Of Tax | -$35.5M | -$41.6M | -$50.9M | -$36.2M | -$52.5M | -$37.3M | -$45.7M | -$51.9M | -$135.8M | -$59.0M | -$160.7M | -$92.8M | -$129.9M | -$125.8M | -$123.8M | -$110.4M | -$72.4M | -$144.5M | -$99.2M | -$108.0M | -$114.9M | -$97.5M | $970.3M | -$96.5M | $60.6M | -$59.7M | -$63.4M | -$43.2M | -$48.8M | -$19.2M | -$8.5M | -$52.9M | $34.1M | $70.3M | -$32.6M | -$46.0M | -$16.9M | -$43.7M | -$55.1M | -$42.8M | -$34.9M | -$40.0M | -$25.8M | -$36.4M | -$36.2M | |||||||||||||||
| General And Administrative Expense | $16.1M | $17.1M | $24.3M | $19.0M | $20.5M | $20.1M | $21.1M | $17.9M | $21.1M | $22.5M | $20.5M | $27.3M | $29.5M | $29.6M | $31.7M | $27.0M | $24.3M | $26.2M | $24.0M | $22.6M | $25.0M | $18.7M | $20.3M | $18.7M | $12.1M | $16.0M | $12.0M | $10.3M | $11.0M | $10.2M | $9.5M | $10.2M | $10.3M | $9.1M | $9.6M | $9.9M | $10.6M | $9.2M | $10.8M | $10.1M | $10.3M | $10.4M | $11.5M | $12.4M | $11.2M | $11.7M | $11.6M | $10.2M | $10.2M | $9.0M | ||||||||||
| Other Nonoperating Income Expense | -$121.0K | $260.0K | $266.0K | -$120.0K | -$36.0K | -$99.0K | -$335.0K | $736.0K | -$301.0K | $2.1M | $1.1M | $395.0K | $131.0K | $845.0K | $1.4M | $2.9M | $5.2M | $8.4M | $11.5M | $12.0M | $12.5M | $11.8M | $12.1M | $1.6M | $1.6M | $906.0K | $658.0K | $332.0K | $458.0K | $875.0K | $898.0K | $246.0K | $211.0K | $126.0K | $96.0K | $312.0K | $262.0K | -$6.0K | $127.0K | $156.0K | $97.0K | $660.0K | -$717.0K | -$16.0K | $134.0K | $249.0K | $163.0K | $24.0K | ||||||||||||
| Nonoperating Income Expense | -$3.3M | -$3.2M | -$1.8M | -$2.7M | -$2.5M | -$1.4M | -$1.0M | -$570.0K | -$2.4M | -$4.9M | -$6.1M | $26.3M | -$16.0M | -$15.0M | -$13.5M | -$5.5M | -$2.1M | -$4.8M | $254.0K | $783.0K | $1.2M | $1.6M | $1.7M | -$8.8M | -$8.4M | -$9.1M | -$9.3M | -$10.2M | -$10.2M | -$9.8M | -$8.5M | -$9.0M | -$9.0M | -$9.5M | -$9.5M | -$9.6M | -$9.8M | -$9.9M | -$9.7M | -$10.4M | -$7.2M | -$3.0M | -$2.6M | -$2.1M | -$2.0M | -$2.2M | -$2.4M | -$2.5M | ||||||||||||
| Income Tax Expense Benefit | -$33.0K | -$188.0K | $52.0K | $9.0K | $46.0K | -$35.0K | -$61.0K | -$47.0K | -$63.0K | -$155.0K | $100.0K | $126.0K | $112.0K | $357.0K | $92.0K | $21.0K | $144.0K | $200.0K | $99.0K | $99.0K | $137.0K | -$900.0K | $3.9M | $265.0K | $202.0K | $99.0K | $133.0K | $139.0K | $127.0K | $167.0K | $92.0K | $164.0K | $213.0K | $248.0K | $195.0K | $191.0K | $193.0K | $205.0K | $212.0K | $222.0K | $93.0K | $124.0K | $92.0K | $60.0K | $148.0K | $278.0K | $31.0K | $308.0K | ||||||||||||
| Non Cash Interest Expense Related To Sale Of Royalties | $6.0M | $5.4M | $5.0M | $6.0M | $6.4M | $5.5M | $5.9M | $6.2M | $6.4M | $7.0M | $7.2M | $7.5M | $12.8M | $13.1M | $13.3M | $8.4M | $6.7M | $7.0M | $5.8M | $6.0M | $6.1M | $4.8M | $5.0M | $5.0M | $4.5M | $4.5M | $4.6M | $4.9M | $5.0M | $5.0M | $5.2M | $5.2M | $5.1M | $5.2M | $5.1M | $5.4M | $5.6M | $5.5M | ||||||||||||||||||||||
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 | $647.0K | $6.2M | $5.4M | $5.2M | $5.2M | $5.4M | $5.4M | $5.3M | $5.5M | $5.5M | $5.4M | $5.6M | $5.6M | $5.7M | $4.2M | $4.1M | $4.2M | $4.4M | $4.5M | $4.5M | $4.6M | $4.7M | $4.6M | $5.7M | $2.6M | $2.5M | -$2.5M | $2.5M | $2.6M | $2.6M | -$2.5M | -$2.8M | -$2.9M | -$3.0M | ||||||||||||||||||||||
| Non Cash Royalty Revenue Related To Sale Of Future Royalties | $10.5M | $15.5M | $16.9M | $17.6M | $18.8M | $9.9M | $8.2M | $6.9M | $8.1M | $6.6M | $6.7M | $7.7M | $8.1M | $6.5M | $6.1M | $4.7M | $4.0M | $6.1M | $4.8M | $5.8M | $4.5M | $3.8M | $4.4M | $3.4M | $3.5M | |||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$37.0M | -$52.3M | -$36.8M | -$45.9M | -$51.2M | -$137.1M | -$59.2M | -$159.0M | -$90.3M | -$129.6M | -$125.2M | -$122.9M | -$108.6M | -$79.9M | -$138.5M | -$98.5M | -$110.2M | -$119.5M | -$97.0M | $975.3M | -$95.5M | $61.1M | -$59.8M | -$63.7M | -$43.1M | -$48.5M | -$19.3M | -$8.1M | -$52.5M | $34.0M | $70.9M | -$32.4M | -$46.0M | |||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $70.0K | -$53.0K | -$22.0K | $849.0K | -$91.0K | -$483.0K | $98.0K | -$769.0K | $1.2M | $22.0K | -$1.7M | -$2.4M | -$163.0K | -$279.0K | -$826.0K | -$1.8M | $7.6M | -$5.9M | -$621.0K | $2.3M | $4.7M | -$1.4M | -$1.2M | -$685.0K | ||||||||||||||||||||||||||||||||||||
| License Collaboration Other Revenue | $13.7M | $131.1M | $4.8M | $6.1M | $8.4M | $8.3M | $34.2M | $46.5M | $6.2M | $96.7M | $120.6M | $17.8M | $8.1M | $41.4M | $19.4M | $6.5M | $6.1M | $10.2M | $7.8M | $6.6M | $16.8M | $6.3M | $6.5M | $32.6M | $30.7M | $31.4M | $29.7M | |||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.0K | $6.0K | -$1.0K | -$28.0K | -$1.0K | -$8.0K | -$98.0K | -$1.0M | $139.0K | -$468.0K | -$671.0K | -$284.0K | $13.0K | -$215.0K | -$60.0K | $349.0K | -$96.0K | -$751.0K | -$360.0K | $108.0K | $35.0K | |||||||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $69.0K | -$59.0K | -$21.0K | $877.0K | -$90.0K | -$475.0K | $196.0K | $244.0K | $1.1M | $490.0K | -$988.0K | -$2.1M | -$176.0K | -$64.0K | -$766.0K | -$2.1M | $7.7M | -$5.1M | -$261.0K | $2.2M | $4.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $89.8M | $60.7M | $131.0M | $366.6M | $679.5M | $1.08B | $1.41B | $1.72B | $87.8M | $88.1M | $6.4M | $36.3M | -$89.9M | $47.0M | $197.8M | $90.7M | $102.4M | $190.2M |
| Cash And Cash Equivalents At Carrying Value | $15.1M | $44.3M | $35.3M | $88.2M | $25.2M | $199.0M | $96.4M | $194.9M | $4.8M | $55.6M | $12.4M | $39.1M | $25.4M | $15.3M | $17.8M | $49.6M | $155.6M | |
| Retained Earnings Accumulated Deficit | -$3.76B | -$3.60B | -$3.48B | -$3.20B | -$2.83B | -$2.31B | -$1.86B | -$1.42B | -$2.12B | -$2.02B | -$1.87B | -$1.79B | -$1.73B | -$1.57B | -$1.40B | -$1.26B | ||
| Property Plant And Equipment Net | $2.1M | $3.4M | $18.9M | $32.5M | $60.5M | $59.7M | $65.7M | $48.9M | $47.5M | $65.6M | $71.3M | $70.4M | $67.0M | $72.2M | $78.6M | $89.8M | ||
| Preferred Stock Share Designated | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.1M | $3.1M | ||
| Other Assets Current | $20.5M | $6.1M | $9.8M | $15.8M | $23.3M | $21.9M | $15.4M | $21.3M | $7.8M | $10.1M | $9.8M | $8.8M | $5.2M | $13.4M | $17.9M | $5.7M | ||
| Liabilities Current | $53.5M | $61.4M | $51.3M | $68.2M | $85.2M | $115.8M | $353.9M | $82.0M | $56.2M | $72.2M | $61.2M | $64.0M | $98.2M | $78.5M | $275.5M | $64.1M | ||
| Liabilities And Stockholders Equity | $280.4M | $303.9M | $398.0M | $710.6M | $1.12B | $1.54B | $1.98B | $2.15B | $508.9M | $568.9M | $498.6M | $441.6M | $434.5M | $497.8M | $606.6M | $521.2M | ||
| Liabilities | $190.6M | $243.1M | $267.0M | $344.0M | $437.7M | $461.5M | $572.0M | $432.6M | $421.0M | $480.7M | $492.2M | $405.3M | $524.4M | $450.8M | $408.7M | $430.6M | ||
| Common Stock Value | $2.0K | $1.0K | $19.0K | $19.0K | $19.0K | $18.0K | $17.0K | $17.0K | $15.0K | $15.0K | $13.0K | $13.0K | $11.0K | $11.0K | $11.0K | $9.0K | ||
| Assets Current | $266.3M | $261.3M | $330.7M | $546.0M | $795.6M | $1.14B | $1.42B | $1.44B | $326.8M | $426.0M | $350.1M | $288.2M | $257.9M | $314.6M | $276.7M | $354.0M | ||
| Assets | $280.4M | $303.9M | $398.0M | $710.6M | $1.12B | $1.54B | $1.98B | $2.15B | $508.9M | $568.9M | $498.6M | $441.6M | $434.5M | $497.8M | $606.6M | $521.2M | ||
| Additional Paid In Capital Common Stock | $3.85B | $3.66B | $3.61B | $3.57B | $3.52B | $3.39B | $3.27B | $3.15B | $2.21B | $2.11B | $1.88B | $1.82B | $1.64B | $1.62B | $1.60B | $1.35B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $17.0K | $61.0K | $80.0K | -$6.9M | -$4.2M | -$2.3M | -$1.0M | -$6.3M | -$2.1M | -$2.4M | -$2.2M | -$1.6M | -$1.2M | -$357.0K | -$1.1M | $968.0K | ||
| Accounts Payable Current | $10.8M | $11.6M | $9.8M | $13.0M | $9.7M | $22.1M | $19.2M | $5.9M | $4.8M | $2.8M | $2.4M | $2.7M | $9.1M | $2.9M | $3.0M | $7.2M | ||
| Other Liabilities Noncurrent | $8.6M | $7.2M | $4.6M | $7.6M | $3.6M | $9.0M | $768.0K | $10.0M | $6.0M | $7.2M | $9.7M | $14.7M | $19.3M | $10.8M | $7.2M | $5.6M | ||
| Other Assets Noncurrent | $5.6M | $4.6M | $4.6M | $2.2M | $2.7M | $1.5M | $344.0K | $4.2M | $994.0K | $817.0K | $754.0K | $6.6M | $8.2M | $9.4M | $999.0K | $972.0K | ||
| Inventory Net | $0.00 | $16.1M | $19.2M | $15.8M | $15.3M | $12.7M | $11.4M | $10.7M | $11.1M | $11.3M | $13.0M | $13.5M | $18.3M | $12.7M | $7.3M | |||
| Accounts Receivable Net Current | $0.00 | $1.2M | $6.0M | $22.5M | $38.9M | $36.8M | $43.2M | $5.0M | $15.7M | $19.9M | $3.6M | $2.2M | $5.8M | $4.9M | $25.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.1M | $44.3M | $35.3M | $88.2M | $25.2M | $199.0M | $96.4M | $194.9M | $4.8M | $59.6M | ||||||||
| Goodwill | $0.00 | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | ||||
| Employee Related Liabilities Current | $9.6M | $15.7M | $14.5M | $11.5M | $9.9M | $8.3M | $18.3M | $6.0M | $5.7M | $14.3M | $8.8M | $12.8M | $9.3M | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Liability Related To Sale Of Potential Future Royalties Non Current Net Of Issuance Costs | $63.2M | $91.8M | $112.6M | $155.4M | $195.4M | $200.3M | $72.0M | $82.9M | $94.7M | $106.0M | $116.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $85.1M | -$24.2M | $13.7M | $48.9M | $79.7M | $126.7M | $159.4M | $197.0M | $240.9M | $412.2M | $458.7M | $607.9M | $801.5M | $905.0M | $994.5M | $1.17B | $1.26B | $1.30B | $1.49B | $1.56B | $1.63B | $1.79B | $1.86B | $58.3M | $84.2M | $3.4M | $44.7M | -$67.9M | -$39.3M | -$275.0K | $39.1M | $35.1M | $77.3M | $47.2M | -$35.4M | -$9.8M | -$50.3M | -$40.5M | -$2.6M | $95.3M | $132.3M | $162.5M | $230.8M | $251.3M | $281.2M | ||||||
| Cash And Cash Equivalents At Carrying Value | $41.0M | $43.0M | $38.9M | $30.1M | $27.9M | $48.6M | $64.9M | $50.7M | $77.0M | $105.8M | $77.5M | $68.0M | $54.0M | $152.3M | $150.2M | $55.8M | $58.2M | $227.0M | $81.2M | $85.4M | $106.8M | $222.3M | $911.1M | $34.8M | $38.0M | $16.1M | $23.5M | $59.6M | $63.3M | $55.7M | $72.5M | $18.8M | $20.9M | $129.5M | $32.0M | $30.7M | $32.4M | $65.4M | $41.4M | $28.5M | $10.3M | $136.2M | $148.5M | $43.0M | $11.6M | $22.5M | $12.9M | $23.2M | $20.6M | ||
| Retained Earnings Accumulated Deficit | -$3.72B | -$3.69B | -$3.65B | -$3.60B | -$3.57B | -$3.51B | -$3.44B | -$3.39B | -$3.34B | -$3.14B | -$3.08B | -$2.92B | -$2.69B | -$2.56B | -$2.43B | -$2.19B | -$2.08B | -$2.00B | -$1.75B | -$1.65B | -$1.54B | -$1.33B | -$1.23B | -$2.20B | -$2.08B | -$2.14B | -$2.09B | -$1.98B | -$1.94B | -$1.89B | -$1.81B | -$1.81B | -$1.75B | -$1.74B | -$1.81B | -$1.78B | -$1.68B | -$1.67B | -$1.63B | -$1.52B | -$1.47B | -$1.44B | -$1.36B | -$1.34B | -$1.30B | ||||||
| Property Plant And Equipment Net | $2.8M | $3.0M | $3.2M | $3.6M | $15.2M | $17.5M | $19.9M | $22.6M | $27.1M | $36.8M | $39.8M | $61.0M | $58.8M | $58.6M | $58.5M | $60.2M | $61.4M | $62.3M | $64.6M | $65.5M | $58.2M | $44.9M | $45.0M | $46.3M | $62.4M | $64.9M | $66.6M | $65.6M | $67.8M | $69.9M | $72.5M | $72.2M | $69.3M | $69.3M | $71.1M | $73.0M | $65.1M | $67.8M | $70.1M | $73.3M | $73.7M | $75.6M | $81.6M | $85.4M | $87.6M | ||||||
| Preferred Stock Share Designated | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.1M | $3.1M | $3.1M | ||||||
| Other Assets Current | $11.1M | $10.7M | $11.3M | $8.9M | $8.3M | $10.7M | $9.0M | $9.6M | $11.0M | $22.5M | $19.2M | $20.8M | $20.7M | $12.6M | $15.8M | $21.6M | $37.8M | $13.8M | $15.2M | $13.2M | $19.4M | $12.5M | $34.9M | $13.1M | $13.3M | $7.5M | $7.9M | $4.0M | $5.4M | $5.6M | $5.2M | $8.8M | $6.1M | $4.7M | $4.6M | $6.0M | $4.8M | $6.0M | $8.8M | $7.0M | $9.3M | $13.6M | $7.6M | $7.9M | $6.9M | ||||||
| Liabilities Current | $66.3M | $71.4M | $70.9M | $67.6M | $57.3M | $52.4M | $52.1M | $50.7M | $59.9M | $84.0M | $105.0M | $105.3M | $140.0M | $131.0M | $123.6M | $126.5M | $124.0M | $377.5M | $125.4M | $113.4M | $99.7M | $108.1M | $96.9M | $80.7M | $92.5M | $72.6M | $78.5M | $76.3M | $79.3M | $65.9M | $208.1M | $81.1M | $75.4M | $80.5M | $84.4M | $79.3M | $80.9M | $90.3M | $83.2M | $69.5M | $276.9M | $270.8M | $279.0M | $61.3M | $58.9M | ||||||
| Liabilities And Stockholders Equity | $301.3M | $207.5M | $256.2M | $308.0M | $343.3M | $396.0M | $442.2M | $494.3M | $561.7M | $781.0M | $862.0M | $1.02B | $1.28B | $1.37B | $1.46B | $1.51B | $1.59B | $1.89B | $2.09B | $2.10B | $2.17B | $2.25B | $2.31B | $496.8M | $582.1M | $475.9M | $528.5M | $425.1M | $463.1M | $491.9M | $449.2M | $456.7M | $499.2M | $476.9M | $478.1M | $487.0M | $383.0M | $412.8M | $447.9M | $541.5M | $668.4M | $694.8M | $648.1M | $670.9M | $704.5M | ||||||
| Liabilities | $216.3M | $231.7M | $242.5M | $259.1M | $263.6M | $269.3M | $282.9M | $297.3M | $320.9M | $368.8M | $403.3M | $416.2M | $475.7M | $466.4M | $462.1M | $337.7M | $338.6M | $591.5M | $599.6M | $542.5M | $533.0M | $459.0M | $452.7M | $438.5M | $497.9M | $472.5M | $483.7M | $492.9M | $502.4M | $492.2M | $410.2M | $421.6M | $421.9M | $429.7M | $513.5M | $496.8M | $433.3M | $453.4M | $450.5M | $446.1M | $536.2M | $532.3M | $417.3M | $419.6M | $423.2M | ||||||
| Common Stock Value | $2.0K | $1.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $16.0K | $15.0K | $15.0K | $15.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | ||||||
| Assets Current | $281.4M | $186.6M | $229.9M | $286.5M | $295.2M | $319.8M | $399.0M | $441.1M | $491.1M | $599.5M | $665.5M | $733.5M | $986.1M | $1.06B | $1.10B | $1.04B | $1.15B | $1.43B | $1.58B | $1.60B | $1.49B | $1.51B | $1.91B | $336.0M | $382.8M | $288.2M | $381.0M | $282.5M | $318.3M | $344.8M | $286.4M | $302.2M | $347.3M | $324.1M | $298.2M | $304.8M | $207.9M | $234.4M | $267.0M | $346.9M | $468.3M | $420.7M | $297.6M | $389.1M | $539.4M | ||||||
| Assets | $301.3M | $207.5M | $256.2M | $308.0M | $343.3M | $396.0M | $442.2M | $494.3M | $561.7M | $781.0M | $862.0M | $1.02B | $1.28B | $1.37B | $1.46B | $1.51B | $1.59B | $1.89B | $2.09B | $2.10B | $2.17B | $2.25B | $2.31B | $496.8M | $582.1M | $475.9M | $528.5M | $425.1M | $463.1M | $491.9M | $449.2M | $456.7M | $499.2M | $476.9M | $478.1M | $487.0M | $383.0M | $412.8M | $447.9M | $541.5M | $668.4M | $694.8M | $648.1M | $670.9M | $704.5M | ||||||
| Additional Paid In Capital Common Stock | $3.81B | $3.67B | $3.66B | $3.65B | $3.65B | $3.64B | $3.60B | $3.59B | $3.58B | $3.56B | $3.55B | $3.54B | $3.49B | $3.47B | $3.43B | $3.36B | $3.34B | $3.31B | $3.24B | $3.21B | $3.18B | $3.12B | $3.09B | $2.26B | $2.17B | $2.15B | $2.13B | $1.91B | $1.90B | $1.89B | $1.85B | $1.84B | $1.83B | $1.79B | $1.78B | $1.77B | $1.64B | $1.63B | $1.62B | $1.61B | $1.61B | $1.60B | $1.59B | $1.59B | $1.58B | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $56.0K | -$14.0K | $39.0K | $355.0K | -$494.0K | -$403.0K | -$6.4M | -$6.5M | -$5.7M | -$8.2M | -$8.2M | -$6.5M | -$3.6M | -$3.4M | -$3.1M | -$1.1M | $715.0K | -$6.9M | -$1.2M | -$788.0K | -$2.7M | -$5.4M | -$4.0M | -$2.8M | -$1.9M | -$1.7M | -$1.8M | -$2.0M | -$2.0M | -$1.8M | -$1.8M | -$1.5M | -$1.3M | -$1.2M | -$887.0K | -$940.0K | -$1.7M | -$1.3M | -$395.0K | $155.0K | -$620.0K | -$43.0K | -$987.0K | $766.0K | $818.0K | ||||||
| Accounts Payable Current | $15.6M | $14.3M | $17.8M | $8.6M | $6.5M | $8.8M | $3.3M | $2.6M | $3.7M | $5.3M | $12.3M | $12.6M | $23.7M | $19.7M | $22.4M | $15.5M | $19.2M | $21.8M | $22.0M | $9.3M | $11.0M | $7.5M | $10.7M | $11.4M | $8.6M | $6.2M | $7.0M | $7.1M | $2.3M | $2.3M | $2.3M | $2.8M | $5.0M | $5.4M | $7.4M | $3.1M | $3.7M | $5.6M | $4.2M | $2.6M | $3.1M | $1.8M | $2.2M | $3.2M | $3.5M | ||||||
| Other Liabilities Noncurrent | $5.0M | $5.6M | $6.8M | $6.9M | $8.1M | $4.3M | $5.0M | $5.2M | $6.5M | $3.1M | $2.1M | $2.7M | $3.9M | $4.0M | $4.1M | $3.3M | $2.2M | $643.0K | $643.0K | $666.0K | $7.6M | $7.1M | $6.5M | $6.0M | $3.6M | $4.1M | $5.5M | $6.0M | $6.5M | $10.7M | $16.7M | $17.1M | $15.4M | $17.8M | $17.8M | $9.2M | $8.6M | $9.0M | $10.7M | $10.2M | $10.8M | $6.5M | $5.8M | $6.2M | |||||||
| Other Assets Noncurrent | $5.2M | $5.0M | $5.4M | $4.5M | $4.3M | $4.7M | $4.5M | $1.7M | $1.4M | $2.3M | $2.2M | $1.5M | $1.8M | $344.0K | $1.4M | $1.4M | $1.4M | $2.4M | $2.4M | $2.4M | $3.4M | $3.4M | $789.0K | $767.0K | $1.1M | $865.0K | $519.0K | $504.0K | $681.0K | $13.9M | $5.8M | $6.2M | $7.0M | $7.3M | $7.8M | $8.5M | $9.0M | $9.3M | $9.7M | $5.7M | $5.3M | $845.0K | $936.0K | $976.0K | |||||||
| Inventory Net | $0.00 | $14.5M | $16.2M | $15.1M | $20.7M | $20.2M | $19.1M | $17.0M | $15.4M | $15.3M | $14.6M | $16.8M | $12.9M | $12.6M | $14.3M | $13.7M | $13.2M | $11.8M | $13.3M | $11.9M | $10.7M | $13.7M | $11.0M | $13.0M | $10.8M | $10.3M | $11.3M | $10.4M | $10.1M | $12.5M | $11.7M | $14.1M | $12.9M | $15.1M | $20.5M | $18.4M | $16.8M | $14.7M | $14.1M | $10.7M | $9.8M | $11.7M | |||||||||
| Accounts Receivable Net Current | $0.00 | $1.2M | $3.6M | $2.2M | $1.3M | $3.0M | $11.5M | $10.0M | $30.2M | $29.0M | $28.9M | $29.2M | $42.9M | $47.2M | $42.0M | $41.2M | $37.3M | $42.9M | $31.9M | $35.3M | $15.6M | $3.3M | $4.1M | $1.6M | $14.2M | $27.8M | $39.7M | $3.0M | $3.7M | $2.9M | $46.1M | $3.0M | $1.9M | $4.6M | $6.0M | $3.6M | $3.9M | $11.4M | $10.8M | $12.9M | $8.5M | $2.2M | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $41.0M | $43.0M | $38.9M | $30.1M | $27.9M | $48.6M | $64.9M | $50.7M | $77.0M | $105.8M | $77.5M | $68.0M | $54.0M | $152.3M | $150.2M | $55.8M | $58.2M | $227.0M | $81.2M | $85.4M | $106.8M | $222.3M | $911.1M | ||||||||||||||||||||||||||||
| Goodwill | $0.00 | $0.00 | $0.00 | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | $76.5M | ||||||||||||
| Employee Related Liabilities Current | $24.4M | $30.3M | $22.7M | $32.9M | $28.7M | $23.5M | $29.5M | $22.5M | $22.4M | $23.1M | $19.7M | $18.4M | $27.9M | $19.0M | $15.1M | $19.1M | $14.3M | $11.5M | $15.7M | $12.5M | $10.0M | $12.8M | $10.8M | $9.4M | $13.8M | $11.4M | $9.4M | $13.9M | $11.1M | $9.0M | $12.7M | $10.5M | $8.2M | $11.8M | $9.4M | $7.7M | |||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||
| Liability Related To Sale Of Potential Future Royalties Non Current Net Of Issuance Costs | $75.2M | $80.6M | $86.3M | $97.8M | $107.5M | $117.9M | $123.6M | $135.7M | $145.1M | $165.6M | $176.8M | $185.6M | $181.8M | $188.1M | $195.1M | $66.4M | $68.3M | $69.2M | $73.5M | $77.8M | $80.8M | $85.4M | $88.9M | $92.8M | $98.4M | $101.9M | $103.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $12.6M | $21.6M | $33.4M | $57.3M | $94.7M | $94.3M | $99.8M | $88.1M | $36.6M | $25.9M | $19.7M | $17.0M | $17.7M | $16.2M | $18.9M | $17.4M | $10.3M |
| Financing Cash Flow * | $180.6M | $42.1M | $30.0K | $1.5M | $36.2M | -$80.4M | $23.4M | $852.0M | $54.4M | $203.6M | $130.8M | $153.0M | $2.2M | $26.8M | $222.3M | $7.5M | $3.5M |
| Investing Cash Flow * | -$1.2M | $142.6M | $139.6M | $365.8M | $202.8M | $496.2M | $206.9M | -$1.38B | -$28.8M | -$82.4M | -$14.3M | -$37.6M | $49.9M | $113.0M | -$112.0M | $16.7M | -$149.0M |
| Operating Cash Flow * | -$208.5M | -$175.7M | -$192.6M | -$304.0M | -$412.7M | -$313.3M | -$328.7M | $718.2M | -$80.4M | -$117.0M | -$73.1M | -$142.0M | -$38.5M | -$129.8M | -$113.7M | -$55.9M | $39.7M |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $284.7M | $340.4M | $650.9M | $826.2M | $1.17B | $1.45B | $1.61B | $891.0M | $347.7M | $253.7M | $226.9M | $248.0M | $319.2M | $307.9M | $383.1M | $475.8M | $310.7M |
| Payments To Acquire Property Plant And Equipment | $171.0K | $1.5M | $865.0K | $5.7M | $15.0M | $7.3M | $26.3M | $14.2M | $9.7M | $6.4M | $11.2M | $10.0M | $4.1M | $10.6M | $9.7M | $31.5M | $16.4M |
| Increase Decrease In Other Operating Assets | $15.4M | $4.2M | -$3.6M | -$6.9M | $2.6M | -$4.5M | -$1.2M | $31.7M | $4.8M | $312.0K | $825.0K | $3.3M | -$6.4M | -$6.0M | $12.3M | -$577.0K | $200.0K |
| Increase Decrease In Inventories | $0.00 | -$497.0K | -$699.0K | $3.4M | $509.0K | $2.6M | $1.3M | $655.0K | -$383.0K | -$237.0K | -$1.6M | -$500.0K | -$4.8M | $5.6M | $5.4M | $795.0K | -$2.8M |
| Increase Decrease In Accounts Receivable | $0.00 | $3.0M | -$4.8M | -$16.5M | -$12.4M | -$1.9M | -$6.4M | $25.5M | -$10.7M | -$4.3M | $16.3M | $1.4M | -$3.6M | $867.0K | -$20.2M | $20.3M | -$6.0M |
| Increase Decrease In Accounts Payable | -$625.0K | $2.7M | -$2.9M | $3.1M | -$11.7M | $2.4M | $13.0M | $971.0K | $2.1M | $518.0K | -$412.0K | -$6.4M | $6.2M | -$122.0K | -$3.4M | $4.3M | -$8.0M |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 866.0K | 118.0K | 30.0K | 758.0K | 33.2M | 23.4M | 23.4M | 61.7M | 59.5M | 20.3M | 32.2M | 47.0M | 8.2M | 4.1M | 4.5M | 8.9M | |
| Stock Issued During Period Value Share Based Compensation | $864.0K | $118.0K | $30.0K | $758.0K | $33.2M | $23.4M | $23.4M | $61.7M | $59.5M | $20.3M | $32.2M | $47.0M | $8.2M | $4.1M | $4.5M | ||
| Increase Decrease In Employee Related Liabilities | -$6.2M | $1.2M | $4.7M | $1.5M | $1.7M | -$10.0M | $12.3M | $249.0K | -$8.5M | $5.5M | -$4.0M | $3.6M | -$800.0K | -$1.5M | |||
| Increase Decrease In Other Accrued Liabilities | -$5.8M | $10.7M | -$17.3M | -$12.7M | -$23.5M | $8.6M | $4.3M | $31.5M | $7.3M | -$71.0K | -$2.3M | $273.0K | -$1.9M | ||||
| Increase Decrease In Other Operating Liabilities | $533.0K | $3.5M | -$14.9M | $8.6M | $3.0M | -$13.8M | $9.2M | $3.3M | -$943.0K | -$247.0K | -$559.0K | ||||||
| Payments To Acquire Available For Sale Securities | $404.4M | $334.7M | $297.6M | $297.3M | $268.1M | $164.7M | $695.4M | $443.1M | $451.9M | ||||||||
| Increase Decrease In Accrued Clinical Trial Expenses | $1.5M | -$262.0K | $512.0K | -$9.2M | -$595.0K | $5.5M | -$191.0K | -$2.0M | -$3.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q1 2014 | Q3 2013 | Q1 2013 | Q3 2012 | Q1 2012 | Q1 2011 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $3.1M | $3.5M | $3.9M | $5.4M | $5.4M | $6.0M | $8.1M | $8.0M | $10.0M | $12.5M | $11.1M | $21.0M | $24.7M | $23.7M | $23.9M | $23.7M | $23.4M | $25.2M | $24.9M | $24.5M | $25.4M | $23.3M | $20.7M | $19.9M | $8.8M | $8.1M | $8.2M | $6.2M | $6.3M | $6.4M | $4.8M | $4.6M | $5.2M | $4.1M | $4.4M | $4.6M | $4.2M | $4.0M | $4.2M | $4.8M | $3.7M |
| Financing Cash Flow * | $7.0K | $42.0M | $0.00 | $938.0K | $17.9M | $11.1M | $4.9M | $34.4M | $11.2M | $4.4M | $587.0K | $113.9M | -$2.5M | $119.5M | $221.5M | $4.4M | |||||||||||||||||||||||||
| Investing Cash Flow * | $43.7M | $19.3M | $40.6M | $130.3M | $10.5M | $197.8M | -$12.1M | $48.2M | -$13.1M | $36.2M | $53.2M | -$58.2M | $43.7M | $48.4M | -$201.9M | $1.0M | |||||||||||||||||||||||||
| Operating Cash Flow * | -$49.1M | -$47.9M | -$51.9M | -$88.4M | -$77.1M | -$78.1M | -$80.9M | -$52.5M | -$34.6M | -$23.6M | $63.3M | -$62.3M | -$38.1M | -$34.6M | -$14.9M | -$34.2M | |||||||||||||||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $69.3M | $124.5M | $148.0M | $228.0M | $303.6M | $439.7M | $362.2M | $37.2M | $58.1M | $69.4M | $73.4M | $57.0M | $100.3M | $152.0M | $113.2M | $112.1M | |||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $2.0K | $157.0K | $433.0K | $4.2M | $2.9M | $900.0K | $5.6M | $985.0K | $4.1M | $1.7M | $1.1M | $4.5M | $316.0K | $1.5M | $3.8M | $4.0M | |||||||||||||||||||||||||
| Increase Decrease In Other Operating Assets | $6.0M | $976.0K | -$5.6M | -$2.9M | -$6.2M | -$1.1M | -$4.2M | -$1.9M | -$2.1M | -$4.3M | -$2.8M | $718.0K | -$3.8M | -$4.3M | $1.2M | $883.0K | |||||||||||||||||||||||||
| Increase Decrease In Inventories | $0.00 | $1.1M | $2.0M | -$422.0K | $1.5M | $1.7M | $397.0K | -$51.0K | $1.9M | -$96.0K | -$441.0K | -$580.0K | $112.0K | $1.5M | $4.4M | $2.2M | |||||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | $0.00 | $2.4M | -$3.0M | $7.7M | -$9.7M | $5.2M | -$319.0K | -$151.0K | -$14.1M | $19.7M | -$722.0K | -$374.0K | -$2.2M | $5.9M | -$22.9M | $2.9M | |||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $6.4M | -$988.0K | -$8.9M | $3.0M | $779.0K | $2.7M | $5.2M | $6.5M | $4.1M | -$34.0K | $2.2M | -$6.1M | $1.4M | -$1.3M | -$2.9M | $1.7M | |||||||||||||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 7.0K | 3.0K | 0.00 | 188.0K | 17.1M | 11.1M | 4.9M | 34.4M | 11.8M | 6.1M | 1.7M | 5.1M | 1.2M | 479.0K | |||||||||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $236.0K | $211.0K | $7.0K | $13.0K | $19.0K | $3.0K | $18.0K | $0.00 | $0.00 | $467.0K | $188.0K | $1.8M | $12.6M | $17.1M | $1.5M | $7.8M | $11.3M | $5.9M | $7.1M | $5.5M | $3.9M | $21.0M | $34.4M | ||||||||||||||||||
| Increase Decrease In Employee Related Liabilities | $6.9M | $9.0M | $9.9M | $8.4M | $6.9M | -$6.8M | $4.0M | $3.6M | -$4.8M | $179.0K | -$4.6M | -$1.6M | -$4.3M | ||||||||||||||||||||||||||||
| Increase Decrease In Other Accrued Liabilities | $1.2M | $1.8M | $1.6M | $14.2M | -$8.0M | $7.5M | $774.0K | $10.8M | $1.8M | $2.2M | $1.8M | ||||||||||||||||||||||||||||||
| Increase Decrease In Other Operating Liabilities | -$233.0K | $164.0K | $545.0K | -$2.5M | $1.7M | $10.3M | -$1.2M | -$3.8M | $556.0K | -$1.5M | -$1.3M | ||||||||||||||||||||||||||||||
| Payments To Acquire Available For Sale Securities | $0.00 | $75.9M | $31.5M | $24.4M | $110.7M | $56.3M | $102.0M | $372.7M | $115.3M | ||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Clinical Trial Expenses | $10.3M | -$515.0K | $2.4M | $1.0M | -$3.2M | $6.5M | $773.0K | $1.5M | $552.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$9.73 | -$8.68 | -$1.45 | -$1.97 | -$2.86 | -$2.49 | -$2.52 | $3.78 | -$0.62 | -$1.10 | -$0.61 | -$0.42 | -$1.40 | -$1.50 | -$1.19 | -$0.40 | -$1.11 |
| Earnings Per Share Basic | $-9.73 | $-8.68 | $-1.45 | $-1.97 | $-2.86 | $-2.49 | $-2.52 | $4.02 | $-0.62 | $-1.10 | |||||||
| Common Stock Shares Authorized | 390.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 20.4M | 12.4M | 191.4M | 188.6M | 185.5M | 180.1M | 176.5M | 173.5M | 159.5M | 153.2M | 135.3M | 131.2M | 116.5M | 115.3M | 114.5M | 94.5M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 16.9M | 13.7M | 190.0M | 187.1M | 183.3M | 178.6M | 175.0M | 169.6M | 156.0M | 139.6M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 16.9M | 13.7M | 190.0M | 187.1M | 183.3M | 178.6M | 175.0M | 180.1M | 156.0M | 139.6M | |||||||
| Common Stock Shares Issued | 20.4M | 12.9M | 191.4M | 188.6M | 185.5M | 180.1M | 176.5M | 173.5M | 159.5M | 153.2M | 135.3M | 131.2M | 116.5M | 115.3M | 114.5M | 94.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.87 | -$2.95 | -$0.24 | -$2.66 | -$3.76 | -$0.19 | -$0.24 | -$0.27 | -$0.73 | -$0.31 | -$0.85 | -$0.49 | -$790.00 | -$0.70 | -$0.69 | -$0.68 | -$0.65 | -$0.61 | -$0.45 | -$0.78 | -$0.64 | -$0.56 | -$0.63 | -$0.69 | -$0.57 | -$0.56 | $5.33 | -$0.60 | -$0.21 | $0.37 | -$0.39 | -$0.42 | -$0.32 | -$0.36 | -$0.14 | -$0.06 | -$0.40 | $0.25 | $0.53 | -$0.26 | -$0.37 | -$0.41 | -$0.14 | -$0.37 | -$0.48 | -$0.46 | -$0.38 | -$0.30 | -$0.36 | -$0.33 | -$0.21 | -$0.32 | -$0.33 | -$0.24 | -$0.09 | -$0.01 | -$0.07 |
| Earnings Per Share Basic | $-1.87 | $-2.95 | $-0.24 | $-2.66 | $-3.76 | $-0.19 | $-0.24 | $-0.27 | $-0.73 | $-0.31 | $-0.85 | $-0.49 | $-790.00 | $-0.70 | $-0.69 | $-0.68 | $-0.65 | $-0.61 | $-0.45 | $-0.78 | $-0.64 | $-0.56 | $-0.63 | $-0.69 | $-0.57 | $-0.56 | $5.67 | $-0.60 | $-0.21 | $0.39 | $-0.39 | $-0.42 | $-0.32 | $-0.14 | $-0.06 | $0.26 | $0.55 | $-0.37 | $-0.14 | ||||||||||||||||||
| Common Stock Shares Authorized | 390.0M | 390.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 | 10.0M | 10.0M | 10.0M | ||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Common Stock Shares Outstanding | 19.7M | 12.5M | 186.1M | 184.5M | 184.1M | 183.6M | 190.8M | 190.1M | 189.2M | 188.0M | 187.4M | 186.3M | 184.6M | 183.8M | 182.3M | 179.4M | 178.8M | 177.9M | 175.8M | 175.0M | 174.2M | 173.1M | 172.4M | 162.4M | 157.0M | 155.9M | 154.7M | 137.8M | 136.6M | 136.2M | 133.2M | 132.2M | 131.5M | 128.2M | 127.3M | 126.9M | 116.0M | 115.7M | 115.5M | 115.1M | 114.8M | 114.6M | 114.4M | 114.3M | 114.0M | ||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 18.9M | 14.1M | 210.9M | 13.9M | 13.9M | 194.7M | 190.4M | 189.7M | 188.9M | 187.6M | 186.8M | 185.8M | 184.1M | 182.7M | 181.4M | 179.1M | 178.3M | 175.4M | 174.5M | 172.7M | 171.4M | 156.4M | 155.4M | 137.1M | 135.8M | 132.6M | 131.4M | 127.5M | 123.5M | 115.8M | |||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 18.9M | 14.1M | 210.9M | 13.9M | 13.9M | 194.7M | 190.4M | 189.7M | 188.9M | 187.6M | 186.8M | 185.8M | 184.1M | 182.7M | 181.4M | 179.1M | 178.3M | 175.4M | 174.5M | 172.7M | 182.3M | 162.6M | 155.4M | 137.1M | 135.8M | 132.6M | 135.7M | 132.2M | 123.5M | 115.8M | |||||||||||||||||||||||||||
| Common Stock Shares Issued | 19.7M | 13.0M | 194.4M | 192.7M | 192.3M | 191.9M | 190.8M | 190.1M | 173.1M | 172.4M | 162.4M | 157.0M | 155.9M | 154.7M | 137.8M | 136.6M | 136.2M | 133.2M | 132.2M | 131.5M | 128.2M | 127.3M | 126.9M | 116.0M | 115.7M | 115.5M | 115.1M | 114.8M | 114.6M | 114.4M | 114.3M | 114.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $195.3M | $203.6M | $353.8M | $468.2M | $548.0M | $578.0M | $554.7M | $505.4M | $367.4M | $278.3M | $260.2M | $217.2M | $269.1M | $222.4M | $195.4M | $187.3M | $167.1M |
| Depreciation And Amortization | $1.0M | $4.4M | $7.8M | $13.0M | $14.1M | $14.2M | $13.2M | $10.9M | $14.7M | $15.4M | $12.9M | $12.9M | $14.3M | $14.5M | $15.0M | $16.6M | $14.9M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.6M | $21.6M | $33.4M | $57.3M | $94.7M | $94.3M | $99.8M | $88.1M | $36.6M | $25.9M | $19.7M | $17.0M | $17.7M | $16.2M | $18.9M | $17.4M | $10.3M |
| Other Noncash Income Expense | $881.0K | $2.2M | $2.4M | $560.0K | -$664.0K | -$2.5M | -$1.4M | -$198.0K | $657.0K | ||||||||
| Investment Income Interest | $10.4M | $14.5M | $19.0M | $6.8M | $2.7M | $732.0K | $2.3M | $2.2M | $1.5M | $3.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 | Q1 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $43.5M | $47.4M | $55.0M | $58.5M | $73.3M | $57.1M | $69.0M | $71.1M | $156.3M | $77.9M | $174.4M | $141.4M | $138.5M | $138.5M | $133.0M | $133.1M | $126.6M | $184.2M | $128.0M | $134.3M | $148.9M | $126.4M | $114.1M | $124.8M | $83.4M | $85.2M | $79.2M | $69.2M | $71.1M | $68.4M | $59.5M | $66.1M | $65.8M | $52.6M | $51.4M | $56.2M | $67.4M | $66.5M | $68.1M | $51.3M | $50.7M | $55.9M | $50.3M | $48.4M | $51.6M | $45.2M | $65.9M | $44.2M | $40.7M | $36.6M |
| Depreciation And Amortization | $426.0K | $1.6M | $2.3M | $3.7M | $3.5M | $4.5M | $3.1M | $2.5M | $4.0M | $3.7M | $3.0M | $3.3M | $3.6M | $3.5M | $3.9M | |||||||||||||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.1M | $3.5M | $3.9M | $5.4M | $5.4M | $6.0M | $8.1M | $8.0M | $10.0M | $12.5M | $11.1M | $21.0M | $24.7M | $23.7M | $23.9M | $23.7M | $24.4M | $24.2M | $24.9M | $24.5M | $25.4M | $23.3M | $20.7M | $19.9M | ||||||||||||||||||||||||||
| Other Noncash Income Expense | $3.1M | $3.1M | -$1.3M | -$2.3M | $1.3M | $3.2M | $370.0K | $731.0K | $617.0K | $938.0K | -$777.0K | -$139.0K | -$295.0K | -$309.0K | ||||||||||||||||||||||||||||||||||||
| Investment Income Interest | $2.8M | $2.0M | $2.9M | $3.4M | $3.9M | $4.2M | $5.2M | $4.8M | $4.3M | $133.0K | $132.0K | $134.0K | $116.0K | $209.0K | $314.0K | $603.0K | $630.0K | $632.0K | $622.0K | $529.0K | $432.0K | $369.0K | $393.0K | $463.0K |
Most recent annual filing with the SEC: March 13, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.